# Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

> **NCT04191577** · PHASE2 · COMPLETED · sponsor: **Cerevance Beta, Inc.** · enrollment: 136 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** CVN424 Low Dose
- **DRUG:** CVN424 High Dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04191577
- **Lead sponsor:** Cerevance Beta, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-02
- **Primary completion:** 2021-11-06
- **Final completion:** 2021-12-13
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04191577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04191577, "Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04191577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*